Notice of Intent To Grant Partially Exclusive License, 10563-10564 [E7-4099]

Download as PDF Federal Register / Vol. 72, No. 45 / Thursday, March 8, 2007 / Notices on January 23, 2007 certification to include all workers of Weyerhaeuser Company, Aberdeen, Washington engaged in the production of softwood dimensional lumber. Consequently, further investigation in this case would duplicate efforts and serve no purpose; therefore the investigation has been terminated. Signed in Washington, DC, this 26th day of February 2007. Elliott S. Kushner, Certifying Officer, Division of Trade Adjustment Assistance. [FR Doc. E7–4064 Filed 3–7–07; 8:45 am] BILLING CODE 4510–FN–P DEPARTMENT OF LABOR Employment and Training Administration [TA–W–61,003] Yamaha Corporation of America, Grand Rapids, MI; Notice of Termination of Investigation Pursuant to Section 221 of the Trade Act of 1974, an investigation was initiated on February 22, 2007, in response to a petition filed by a company official on behalf of workers at Yamaha Corporation of America, Grand Rapids, Michigan. This petitioning group of workers is covered by an earlier petition (TA–W– 60,996) filed on February 21, 2007 that is the subject of an ongoing investigation for which a determination has not yet been issued. Consequently, further investigation in this case would duplicate efforts and serve no purpose; therefore the investigation has been terminated. Signed in Washington, DC, this 27th day of February 2007. Elliott S. Kushner, Certifying Officer, Division of Trade Adjustment Assistance. [FR Doc. E7–4067 Filed 3–7–07; 8:45 am] BILLING CODE 4510–FN–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice 07–022] Notice of Intent To Grant Partially Exclusive License National Aeronautics and Space Administration. ACTION: Notice of intent to grant exclusive license sroberts on PROD1PC70 with NOTICES AGENCY: SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(c)(1) and VerDate Aug<31>2005 18:53 Mar 07, 2007 Jkt 211001 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license worldwide to practice the inventions described and claimed in U.S. Patent Nos. 5,155,035, entitled ‘‘ Method for Culturing Mammalian Cells in a Perfused Bioreactor’’; 5,153,133, entitled ‘‘Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor’’; 5,155,034, entitled ‘‘Three Dimensional Cell to Tissue Assembly Process’’; 5,153,132, entitled ‘‘Three-Dimensional Co-culture Process’’; 5,308,764, entitled ‘‘Multi-Cellular Three-Dimensional Living Mammalian Tissue’’; 5,627,021, entitled ‘‘Three-Dimensional Co-Culture Process’’; 5,153,131, entitled ‘‘High Aspect Reactor Vessel and Method of Use’’; 5,496,722, entitled ‘‘Method for Producing Non-neoplastic, Threedimensional, Mammalian Tissue and Cell Aggregates under Microgravity Culture Conditions and the Products Produced Therefrom’’; 5,846,807, entitled ‘‘Media Compositions for Three-dimensional Mammalian Tissue Grown under Microgravity Culture Conditions’’; 5,858,783, entitled ‘‘Production of Normal Mammalian Organ Culture Using a Medium Containing MEM-alpha, Leibovitz L–15, Glucose Galactose Fructose’’; 5,962,324, entitled ‘‘Three Dimensional Optic Tissue Culture and Process’’; 6,485,963, entitled ‘‘Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof’’, 6,673,597, entitled ‘‘Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof’’; 6,730,498, entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’; 6,946,246, entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, U.S. Patent Application Serial Number 10/734,759, entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, U.S. Patent Application Serial Number 10/947,786, entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, Foreign Patent No. 0423277 ‘‘BioReactor Cell Culture Process’’, Foreign Patent No. 1987294, ‘‘Bio-Reactor Cell Culture Process’’, International Application No. PCT/US98/06826, European Application No. 98915320.0 entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, International Application No. PCT/US98/06826, Japanese Application No. 10–540983 entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, International Application No. PCT/US98/06826, PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 10563 Canadian Application No. 2286349 entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, International Application No. PCT/US98/06826, Israeli Application No. 132264 entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, International Application No. PCT/US98/06826, Mexican Application No. 999265 entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, and International Application No. PCT/US98/06826, Brazilian Application No. 98915320.0 entitled ‘‘Production of Functional Proteins: Balance of Shear Stress and Gravity’’, to Aedifico Biosciences, Inc., having its principal place of business in Beverly Hills, California. The fields of use may be limited to cosmetics and personal care products. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective partially exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. DATES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of Chief Counsel, Mail Code AL, 2101 NASA Parkway, Houston, TX 77058, (281) 483–4871; (281) 483–6936 [Facsimile]. ADDRESSES: Kurt G. Hammerle, Patent Attorney, Office of Chief Counsel, Johnson Space Center, Mail Code AL, 2101 NASA Parkway, Houston, TX 77058, (281)483–1001; (281)483–6936 [Facsimile]. Information about other NASA inventions available for licensing can be found online at https://technology.nasa.gov/. FOR FURTHER INFORMATION CONTACT: E:\FR\FM\08MRN1.SGM 08MRN1 10564 Federal Register / Vol. 72, No. 45 / Thursday, March 8, 2007 / Notices Dated: March 1, 2007. Keith T. Sefton, Deputy General Counsel, Administration & Management. [FR Doc. E7–4099 Filed 3–7–07; 8:45 am] BILLING CODE 7510–13–P NATIONAL INSTITUTE FOR LITERACY National Institute for Literacy Advisory Board Meeting National Institute for Literacy. Notice of Open Meeting With Partially Closed Session. AGENCY: ACTION: This notice sets forth the schedule and a summary of the agenda for an upcoming meeting of the National Institute for Literacy Advisory Board (Board). The notice also describes the functions of the Board. Notice of this meeting is required by section 10(a)(2) of the Federal Advisory Committee Act. This document is intended to notify the general public of their opportunity to attend the meeting. Individuals who will need accommodations for a disability in order to attend the meeting (e.g., interpreting services, assistive listening devices, or materials in alternative format) should notify Steve Langley at telephone number (202) 233– 2043 no later than March 19, 2007. We will attempt to meet requests for accommodations after this date but cannot guarantee their availability. The meeting site is accessible to individuals with disabilities. DATE AND TIME: Open sessions—March 28, 2007, from 8:30 a.m. to 5:30 p.m. Closed sessions—March 28, 2007, from 5:30 p.m. to 6 p.m.; and March 29, 2007, from 8:30 a.m. to 2 p.m. ADDRESSES: The National Institute for Literacy, 1775 I Street, NW., Suite 730, Washington, DC 20006. FOR FURTHER INFORMATION CONTACT: Steve Langley, National Institute for Literacy, 1775 I Street, NW., Suite 730, Washington, DC 20006; telephone number: (202) 233–2043; e-mail: slangley@nifl.gov. SUPPLEMENTARY INFORMATION: The Board is established under section 242 of the Workforce Investment Act of 1998, P.L. 105–220 (20 U.S.C. 9252). The Board consists of ten individuals appointed by the President with the advice and consent of the Senate. The Board advises and makes recommendations to the Interagency Group that administers the Institute. The Interagency Group is composed of the Secretaries of Education, Labor, and Health and Human Services. The Interagency Group considers the Board’s recommendations sroberts on PROD1PC70 with NOTICES SUMMARY: VerDate Aug<31>2005 18:53 Mar 07, 2007 Jkt 211001 in planning the goals of the Institute and in implementing any programs to achieve those goals. Specifically, the Board performs the following functions: (a) Makes recommendations concerning the appointment of the Director and the staff of the Institute; (b) provides independent advice on operation of the Institute; and (c) receives reports from the Interagency Group and the Institute’s Director. The National Institute for Literacy Advisory Board will meet March 28–29, 2007. On March 28, 2007 from 8:30 a.m. to 5:30 p.m. and March 29, 2007 from 8:30 a.m. to 2 p.m., the Board will meet in open session to discuss strategic planning and the dissemination plan for the National Early Literacy Panel Report. On March 28, 2007 from 5:30 p.m. to 6 p.m., the Board will meet in closed session to discuss personnel issues. This discussion will relate to the Institute’s internal personnel practices, including consideration of the Director’s performance and salary. The discussion is likely to disclose information of a personal nature where disclosure would constitute a clearly unwarranted invasion of personnel privacy. The discussion must therefore be held in closed session under exemptions 2 and 6 of the Government in the Sunshine Act, 5 U.S.C. 552b(c)(2) and (6). A summary of the activities at the closed session and related matters that are informative to the public and consistent with the policy of 5 U.S.C. 552b will be available to the public within 14 days of the meeting. Records are kept of all Advisory Board proceedings and are available for public inspection at the National Institute for Literacy, 1775 I Street, NW., Suite 730, Washington, DC 20006, from 8:30 a.m. to 5 p.m. Dated: March 2, 2007. Sandra L. Baxter, Director. [FR Doc. E7–4132 Filed 3–7–07; 8:45 am] BILLING CODE 6055–01–P PO 00000 NUCLEAR REGULATORY COMMISSION [Docket No.: 70–1257; License No. SNM– 1227; EA–06–231] In the Matter of Areva Np, Inc. Richland, WA and All Others Who Seek or Obtain Access to Safeguards Information; Described Herein: Order Imposing Fingerprinting and Criminal History Check Requirements for Access to Safeguards Information (Effective Immediately) I AREVA NP, Inc., Richland, (AREVA NP—Richland) is the holder of Special Nuclear Material License No. SNM– 1227 issued by the U.S. Nuclear Regulatory (NRC) pursuant to 10 CFR Part 70. AREVA NP—Richland is authorized, by its license, to receive, possess, and transfer byproduct, source material, and special nuclear material in accordance with the Atomic Energy Act (AEA) of 1954, as amended, and 10 CFR Part 70. On August 8, 2005, the Energy Policy Act of 2005 (EPAct) was enacted. Section 652 of the EPAct amended Section 149 of the AEA to require fingerprinting and a Federal Bureau of Investigation (FBI) identification and criminal history records check of any person who is to be permitted to have access to Safeguards Information (SGI).1 The NRC’s implementation of this requirement cannot await the completion of the SGI rulemaking, which is underway, because the EPAct fingerprinting and criminal history check requirements for access to SGI were immediately effective on enactment of the EPAct. Although the EPAct permits the Commission, by rule, to except certain categories of individuals from the fingerprinting requirement, which the Commission has done [see 10 CFR 73.59, 71 Federal Register 33989 (June 13, 2006)], it is unlikely that licensee employees are excepted from the fingerprinting requirement by the ‘‘fingerprinting relief’’ rule. Individuals relieved from fingerprinting and criminal history checks under the relief rule include: Federal, State, and local officials and law enforcement personnel; Agreement State Inspectors who conduct security inspections on behalf of the NRC; members of Congress and certain employees of members of Congress or Congressional Committees, and representatives of the International 1 Safeguards Information is a form of sensitive, unclassified, security-related information that the Commission has the authority to designate and protect under Section 147 of the AEA. Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

National Aeronautics and Space Administration

[Federal Register Volume 72, Number 45 (Thursday, March 8, 2007)]
[Notices]
[Pages 10563-10564]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4099]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 07-022]


Notice of Intent To Grant Partially Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant exclusive license

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(c)(1) 
and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to 
grant a partially exclusive license worldwide to practice the 
inventions described and claimed in U.S. Patent Nos. 5,155,035, 
entitled `` Method for Culturing Mammalian Cells in a Perfused 
Bioreactor''; 5,153,133, entitled ``Method for Culturing Mammalian 
Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled 
``Three Dimensional Cell to Tissue Assembly Process''; 5,153,132, 
entitled ``Three-Dimensional Co-culture Process''; 5,308,764, entitled 
``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 
5,627,021, entitled ``Three-Dimensional Co-Culture Process''; 
5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 
5,496,722, entitled ``Method for Producing Non-neoplastic, Three-
dimensional, Mammalian Tissue and Cell Aggregates under Microgravity 
Culture Conditions and the Products Produced Therefrom''; 5,846,807, 
entitled ``Media Compositions for Three-dimensional Mammalian Tissue 
Grown under Microgravity Culture Conditions''; 5,858,783, entitled 
``Production of Normal Mammalian Organ Culture Using a Medium 
Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 
5,962,324, entitled ``Three Dimensional Optic Tissue Culture and 
Process''; 6,485,963, entitled ``Growth Stimulation of Biological Cells 
and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, 
entitled ``Growth Stimulation of Biological Cells and Tissue by 
Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled 
``Production of Functional Proteins: Balance of Shear Stress and 
Gravity''; 6,946,246, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', U.S. Patent Application Serial 
Number 10/734,759, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', U.S. Patent Application Serial 
Number 10/947,786, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', Foreign Patent No. 0423277 
``Bio-Reactor Cell Culture Process'', Foreign Patent No. 1987294, 
``Bio-Reactor Cell Culture Process'', International Application No. 
PCT/US98/06826, European Application No. 98915320.0 entitled 
``Production of Functional Proteins: Balance of Shear Stress and 
Gravity'', International Application No. PCT/US98/06826, Japanese 
Application No. 10-540983 entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', International Application No. 
PCT/US98/06826, Canadian Application No. 2286349 entitled ``Production 
of Functional Proteins: Balance of Shear Stress and Gravity'', 
International Application No. PCT/US98/06826, Israeli Application No. 
132264 entitled ``Production of Functional Proteins: Balance of Shear 
Stress and Gravity'', International Application No. PCT/US98/06826, 
Mexican Application No. 999265 entitled ``Production of Functional 
Proteins: Balance of Shear Stress and Gravity'', and International 
Application No. PCT/US98/06826, Brazilian Application No. 98915320.0 
entitled ``Production of Functional Proteins: Balance of Shear Stress 
and Gravity'', to Aedifico Biosciences, Inc., having its principal 
place of business in Beverly Hills, California. The fields of use may 
be limited to cosmetics and personal care products. The patent rights 
in these inventions have been assigned to the United States of America 
as represented by the Administrator of the National Aeronautics and 
Space Administration. The prospective partially exclusive license will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective partially exclusive license may be granted 
unless, within fifteen (15) days from the date of this published 
notice, NASA receives written objections including evidence and 
argument that establish that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. 
Competing applications completed and received by NASA within fifteen 
(15) days of the date of this published notice will also be treated as 
objections to the grant of the contemplated partially exclusive 
license. Objections submitted in response to this notice will not be 
made available to the public for inspection and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act, 5 U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, Mail Code AL, 
2101 NASA Parkway, Houston, TX 77058, (281) 483-4871; (281) 483-6936 
[Facsimile].

FOR FURTHER INFORMATION CONTACT: Kurt G. Hammerle, Patent Attorney, 
Office of Chief Counsel, Johnson Space Center, Mail Code AL, 2101 NASA 
Parkway, Houston, TX 77058, (281)483-1001; (281)483-6936 [Facsimile]. 
Information about other NASA inventions available for licensing can be 
found online at https://technology.nasa.gov/.


[[Page 10564]]


    Dated: March 1, 2007.
Keith T. Sefton,
Deputy General Counsel, Administration & Management.
 [FR Doc. E7-4099 Filed 3-7-07; 8:45 am]
BILLING CODE 7510-13-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.